HIGH

Glenmark Pharmaceuticals Recalls Nebivolol Tablets Over Contamination

Glenmark Pharmaceuticals recalled 672 bottles of Nebivolol Tablets on November 18, 2025, due to cross-contamination. The 20 mg tablets, prescribed for hypertension, may pose health risks. Consumers should stop using the product and seek guidance from healthcare providers.

Quick Facts at a Glance

Recall Date
November 18, 2025
Hazard Level
HIGH
Brands
NEBIVOLOL, AvKARE
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Cross Contamination with Other Products

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Nebivolol is a medication used to treat high blood pressure and heart conditions. It is typically prescribed for hypertension management and can help lower the risk of heart-related issues.

Why This Is Dangerous

The recall was initiated due to cross-contamination with other products, which can compromise the safety and effectiveness of the medication.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers should stop using the product to avoid potential health risks. This recall may cause inconvenience for those relying on the medication.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the bottle.
  2. Verify the expiration date is May 31, 2026.
  3. Confirm the product was purchased from a retailer in the U.S.

Where to find product info

Lot numbers and expiration dates are typically printed on the medicine bottle label.

What timeline to expect

Refund processing can take approximately 4-6 weeks after returning the product.

If the manufacturer is unresponsive

  • Follow up with Glenmark Pharmaceuticals via phone or email.
  • Document all communication and keep records of your return.

How to prevent similar issues

  • Always check for recalls before using medications.
  • Consult with your healthcare provider about any concerns regarding your prescriptions.
  • Be aware of signs of contamination, such as unusual side effects.

Documentation advice

Keep receipts, correspondence regarding the recall, and any evidence of the product for your records.

Product Details

The recall involves Nebivolol Tablets, 20 mg, sold in 90-count bottles. The products were manufactured by Glenmark Pharmaceuticals Limited in India for Avkare, Pulaski, TN. The affected lot number is 17240988, with an expiration date of May 31, 2026.

Key Facts

  • 672 bottles recalled
  • Lot# 17240988
  • Expiration date: 05/31/2026
  • Manufactured for Avkare
  • Distributed nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot# 17240988
Exp. 05/31/2026
UPC Codes
42291-871
42291-872
42291-873
+5 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more